Imatinib Mesylate

Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).

Price Not Available 200 mg Imatinib Mesylate Supplier Page

Catalog Number	T1621
Alternative Name(s)	STI-571 , CGP-57148B , ST-1571 Mesylate
Research Area	Autophagy\|\|\|Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|Cytoskeletal Signaling
Molecular Formula	C29H31N7O·CH4SO3
CAS#	220127-57-1
Purity	99.73%
SMILES	CS(O)(=O)=O.CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1
Size	200 mg
Supplier Page	https://www.targetmol.com/compound/Imatinib Mesylate
Additional Information	https://www.targetmol.com/datasheet/T1621